Incyte risk/reward remains compelling, says Barclays

Barclays analyst Geoff Meacham continues to see “compelling risk/reward profile” for Incyte shares following the company’s Q2 results. Despite signs of commercial strength and the recent positive Reach1 data readout, Incyte shares have remained flat since the end of Q2, Meacham tells investors in a research note. The analyst continues to see upside given the “strong base business” as well as the company’s “attractive and diverse” late-stage pipeline set to begin providing near-term catalysts. He keeps an Overweight rating on Incyte with an $85 price target

https://bit.ly/2LV9H2G